Mark Mullikin, based in Boston, MA, US, is currently a Chief Financial Officer at Ensem Therapeutics. Mark Mullikin brings experience from previous roles at Value Creation Partners, Vedanta Biosciences, Inc. and Editas Medicine. Mark Mullikin holds a MIT Sloan School of Management. With a robust skill set that includes Lifesciences, Financial Modeling, Pharmaceutical Industry, Competitive Analysis, Business Development and more. Mark Mullikin has 3 emails and 2 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.